Media

Registration for this year’s Livestock Biotech Summit is officially open to attendees and credentialed media, the Biotechnology Industry Organization (...
selective group of CEOs and COOs from emerging industrial biotechnology companies will present new technologies, accomplishments, and business cases during...

Press Releases

Mar 8 1999
  WASHINGTON, D.C. (March 8, 1999) The latest scientific, technological and product development activities in biotechnology from around the world will...
Mar 3 1999
Washington, D.C. (March 3, 1999) --- The Biotechnology Industry Organization (BIO) said today it will support Pioneer HiBred International Inc. in efforts to...
Feb 24 1999
NEW YORK, N.Y., (February 24, 1999) -- Twenty-one new biotechnology drugs, vaccines and new indications for existing drugs were approved by the Food and Drug...
Feb 19 1999
  Libby Mikesell, Director of Communications at the Biotechnology Industry Organization (BIO), issued the following statement in response to reports...
Feb 11 1999
  Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on the legislation introduced Wednesday...
Feb 8 1999
WASHINGTON, D.C. (Feb. 8, 1999) Among the investor sessions featured at the Biotechnology Industry Organization's (BIO) annual CEO & Investor...
Jan 19 1999
WASHINGTON, D.C. (Jan. 19, 1999) Fifty-two companies will participate in the annual CEO & Investor Conference organized by the Biotechnology Industry...
Jan 15 1999
BIO has long been concerned about the possible misuse of genetic or medical information. Recent news reports about plans to collect data on the health...
Jan 15 1999
The Biotechnology Industry Organization issued the following statement from its Executive Director, Technical Affairs, Alan Goldhammer, Ph.D.: "Health...


Biotechnology News

April 22, 2014

NEW YORK & SEOUL, South Korea--(BUSINESS WIRE)--Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement

April 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today announced that it is offering to sell, subject to...

April 22, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on April...

April 22, 2014

SAN DIEGO--(BUSINESS WIRE)--Illumina announces earnings results for first quarter 2014.

April 22, 2014

MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today reported 2014 first quarter financial results. First quarter 2014 net sales were $799.3 million, an...